Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies

Anna Carolina Carvalho da Fonseca1, Behnam Badie

  • 1Laboratório de Morfogênese Celular, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Insights

Microglia and macrophages promote malignant glioma growth and invasion. Targeting these immune cells offers a promising strategy for developing novel anti-glioma therapies.

Area of Science:

  • Neuro-oncology
  • Cancer immunology
  • Tumor microenvironment

Background:

  • Malignant gliomas, particularly glioblastoma multiforme (GBM), are aggressive primary brain tumors with poor prognosis.
  • Microglia and macrophages are abundant immune cells within and around brain tumors.
  • These immune cells adopt a tumor-promoting phenotype, enhancing glioma growth and invasion.

Purpose of the Study:

  • To review recent findings on microglia/macrophage interactions in brain tumors.
  • To discuss the potential of targeting these immune cells for future anti-glioma therapies.

Main Methods:

  • Literature review of recent scientific data.
  • Analysis of microglia and macrophage roles in glioma progression.
  • Discussion of therapeutic implications.

Main Results:

  • Microglia and macrophages exhibit tumor-tropic functions in gliomas.
  • These immune cells contribute significantly to glioma growth and invasion.
  • Understanding these interactions is crucial for therapeutic development.

Conclusions:

  • Targeting microglia and macrophages represents a potential therapeutic avenue for malignant gliomas.
  • Further research into immune cell modulation could lead to improved anti-glioma treatments.

Related Concept Videos